Fibroblast-specific Expression of a Kinase-deficient Type II Transforming Growth Factor β (TGFβ) Receptor Leads to Paradoxical Activation of TGFβ Signaling Pathways with Fibrosis in Transgenic Mice

This publication has 54 references indexed in Scilit:

• Dysregulation of transforming growth factor β signaling in scleroderma: Overexpression of endoglin in cutaneous scleroderma fibroblasts
  Arthritis & Rheumatism, 2002
• Transforming growth factor-β1 regulation of growth zone chondrocytes is mediated by multiple interacting pathways
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2002
• Transforming growth factor-β and connective tissue growth factor: key cytokines in scleroderma pathogenesis
  Current Opinion in Rheumatology, 2001
• Hepatocellular expression of a dominant-negative mutant TGF-β type II receptor accelerates chemically induced hepatocarcinogenesis
  Oncogene, 2001
• Activation of a fibroblast-specific enhancer of the Pro?2(I) collagen gene in tight-skin mice
  Arthritis & Rheumatism, 2001
• Loss of TGF-β signaling contributes to autoimmune pancreatitis
  Journal of Clinical Investigation, 2000
• Absence of proximal duct apoptosis in the ventral prostate of transgenic mice carrying the C3(1)-TGF-? type II dominant negative receptor
  The Prostate, 2000
• Expression of TGF-β1, -β2 and -β3 in localized and systemic scleroderma
  Journal of Dermatological Science, 1999
• A potent far-upstream enhancer in the mouse pro alpha 2(I) collagen gene regulates expression of reporter genes in transgenic mice.
  The Journal of cell biology, 1996
• The dopamine β-hydroxylase gene promoter directs expression of E. coli lacZ to sympathetic and other neurons in adult transgenic mice
  Neuron, 1991